Moreover, NLRC5 was identified as a candidate gene to affect HDL-Clevels in humans [111] and single nucleotide polymorphisms (SNP) in NLRC5, and its promotors have been associated with altered triglyceride levels and dyslipidemia [112,113]. Here, NLRC5 is linked to metabolic syndrome.